✦ LIBER ✦

Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with 90Y-biotin?

✍ Scribed by Chiara Grana; Mirco Bartolomei; Daria Handkiewicz; Paola Rocca; Lisa Bodei; Nicoletta Colombo; Marco Chinol; Costantino Mangioni; Fabio Malavasi; Giovanni Paganelli

Book ID: 113959232
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 161 KB
Volume: 93
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.02.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is There a Role for Consolidation or Sal

Is There a Role for Consolidation or Salvage Radiotherapy after Chemotherapy in Advanced Epithelial Ovarian Cancer?

✍ Gillian M. Thomas 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Is There a Role for Bevacizumab in the P

Is There a Role for Bevacizumab in the Primary Treatment of Advanced Ovarian Cancer Off-Protocol?

✍ Meisel, Jane L.; Sabbatini, Paul 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 87 KB

Fractionated radioimmunotherapy with 90Y

Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer : A phase 1 trial

✍ Allyson J. Ocean; Kenneth L. Pennington; Michael J. Guarino; Arif Sheikh; Tanios 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 995 KB

Is there a role for routine axillary ult

Is there a role for routine axillary ultrasound In the pre-operative management of patients with breast cancer?

✍ H. Caretta-Weyer; G.A. Sisney; C.W. Beckman; H.B. Neuman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Clinical Evidence on the Undertreatment

Clinical Evidence on the Undertreatment of Older and Poor Performance Patients Who Have Advanced Non-Small-Cell Lung Cancer: Is There a Role for Targeted Therapy in These Cohorts?

✍ Corey J. Langer 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 404 KB